[Rifampicin in the treatment of active pulmonary tuberculosis. Controlled trial of isoniazid-rifampicin-thiocarlide versus isoniazid-streptomycin-thiocarlide in untreated tuberculosis. Treatment of relapses with the combination rifampicin-ethambutol-thiocarlide].
D056486:Chemical and Drug Induced Liver Injury; D002986:Clinical Trials as Topic; D004342:Drug Hypersensitivity; D004359:Drug Therapy, Combination; D004977:Ethambutol / Q000627:therapeutic use*; D005767:Gastrointestinal Diseases / Q000139:chemically induced; D006801:Humans; D007538:Isoniazid / Q000009:adverse effects / Q000627:therapeutic use*; D009169:Mycobacterium tuberculosis / Q000302:isolation & purification; D010670:Phenylthiourea / Q000031:analogs & derivatives* / Q000627:therapeutic use*; D011736:Pyridoxine / Q000627:therapeutic use; D012008:Recurrence; D012293:Rifampin / Q000009:adverse effects / Q000627:therapeutic use*; D013307:Streptomycin / Q000009:adverse effects / Q000627:therapeutic use*; D013921:Thrombocytopenia / Q000139:chemically induced; D013997:Time Factors; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy* / Q000382:microbiology
C100189:thiocarlide; D010670:Phenylthiourea; D004977:Ethambutol; D011736:Pyridoxine; D007538:Isoniazid; D012293:Rifampin; D013307:Streptomycin
La rifampicine dans le traitement de la tuberculose pulmonaire active. Essai contrôlé isoniazide-rifampicine-thiocarlide versus isoniazide-streptomycine-thiocarlide dans les tuberculoses non traitées. Traitement des rechutes par l'association rifampicine-éthambutol-thiocarlide.